Gyon Technologies Capital Management’s Boston Scientific BSX Stock Holding History

Gyon Technologies Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-13,326	Closed	-$566K	–	306
2021 Q4	$566K	Buy	+13,326	New	+$560K	0.1%	272
2020 Q4	–	Sell	-15,649	Closed	-$598K	–	353
2020 Q3	$598K	Buy	15,649 +249	+2%	+$9.6K	0.47%	74
2020 Q2	$541K	Buy	+15,400	New	+$555K	1.31%	29
2020 Q1	–	Sell	-10,992	Closed	-$497K	–	114
2019 Q4	$497K	Buy	+10,992	New	+$460K	0.33%	84

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Gyon Technologies Capital Management's BSX Position: Q1 2022 in Review

Gyon Technologies Capital Management sold out of Boston Scientific (BSX) in Q1 2022, closing a stake of 13,326 shares — an estimated $566K sold.

Gyon Technologies Capital Management first reported a position in BSX in Q4 2019 and held it in 4 quarters. The position peaked at $598K in Q3 2020. 904 funds tracked by Wall St. Rank hold BSX as of Q1 2022.

Gyon Technologies Capital Management reported no remaining Boston Scientific position as of Q1 2022 after selling out during the quarter.
Gyon Technologies Capital Management sold 13,326 Boston Scientific shares in Q1 2022, an estimated $566K.
Gyon Technologies Capital Management first reported a position in Boston Scientific in Q4 2019 and held it in 4 quarters.
Gyon Technologies Capital Management's Boston Scientific position peaked at $598K in Q3 2020.
904 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2022.

Based on Gyon Technologies Capital Management's 13F filing for Q1 2022, filed 12 May 2022.